These results warrant further clinical investigation, particularly in gastric cancer subtypes characterized by mitochondrial dependence or intrinsic resistance to apoptosis, where ClpP-targeted therapies may provide significant benefits. This evidence concerns the gene CLPP and gastric cancer.